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Abstract 
The synthesis of nanophase hydroxyapatite (nHA) is of importance in the field of 
biomaterials and bone tissue engineering. The bioactive and osteoconductive 
properties of nHA are of much benefit to a wide range of biomedical applications 
such as producing bone tissue engineered constructs, coating medical implants or as a 
carrier for plasmid DNA in gene delivery.  This study aimed to develop a novel low-
temperature dispersant-aided precipitation reaction to produce nHA particles (<100 
nm) which are regarded as being preferable to micron-sized agglomerates of nHA. 
The variables investigated and optimised include the reaction pH, the rate of reactant 
mixing, use of sonication, order of addition and concentration of the primary 
reactants, in addition, the effect of employing poly(vinyl alcohol) (PVA) surfactant 
and Darvan 821A® dispersing agent during the reaction was also examined.  It was 
found that by fine-tuning the synthesis parameters and incorporating the dispersing 
agent, monodisperse, phase-pure nano-sized particles under 100 nm were attained, 
suitable for clinical applications in bone regeneration.  
Keywords 
Hydroxyapatite, Nanoparticle synthesis, Particle size, Darvan dispersant, Suspension 
1. Introduction 
Tissue engineering endeavours to develop biological substitutes that maintain, 
improve or restore tissue and organ functionality damaged through disease, trauma or 
congenital abnormalities 1. In particular, bone tissue engineering seeks to replace bone 
in areas such as non-union fractures, after cancer resection and general trauma by 
using a cell seeded construct which typically involves the use of a suitable scaffold 
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combined with cells and appropriate growth factors 2. If successful, this approach 
would be an alternative to the use of autografts (current ‘gold’ standard) and allografts 
with which many problems exist such as shortage of donors and donor sites, immune 
responses and disease transmission 3,4. Currently however, a tissue engineered bone 
graft replacement has not yet been optimised, despite many promising advances. 
Nanotechnology, or the use of nanophase materials, may provide a solution by 
mimicking the properties of natural bone which is a nanocomposite. It consists 
primarily of a protein-based soft hydrogel template (collagen and non-collagenous 
proteins) and a hard inorganic ceramic phase of which hydroxyapatite 
(Ca10(PO4)6(OH)2, HA) is the chemical and crystallographic template. Typically, 70 
%   of the bone matrix contains nanocrystalline HA which is 20-80 nm long and 2-5 
nm thick 5. Many investigations of nanophase materials to date have illustrated their 
potential for bone repair. For example, increased osteoblast adhesion on nano grained 
materials in comparison to conventional (micron grained) materials has been reported 
6,7
. Osteoblast proliferation in vitro and long-term functions were also enhanced on 
ceramics with grain or fibre sizes less than 100 nm 7,8. In addition to osteoblast 
responses, modified osteoclast behaviour has also been documented on nanophase 
ceramics 6 and in vivo studies have demonstrated increased new bone formation on 
metals coated with nHA compared to conventional apatite 9.  
Bioceramics have been extensively researched for use in engineered bone grafts, and 
amongst them hydroxyapatite (HA) is at the forefront of investigation due to its 
excellent biocompatibility and bioactive properties 10. Clinically it is used in the form 
of powders, granules, coatings, dense and porous blocks, as a non-viral carrier for 
plasmid DNA gene delivery as well as in various biocomposites 11-15. However, 
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micron-sized HA exhibits poor bioresorbability and brittle characterisitics, 16,17 and so 
the study of nanophase HA (nHA) has become more imperative 18-20. 
 
Various methods are reported for the production of HA, including wet chemical 
precipitation, sol-gel processing, solid-state reactions, chemical vapour deposition, 
hydrothermal and reverse micro-emulsion techniques 10,21-25. Of these methods, wet 
precipitation is the most common due to its simplicity and low cost which also makes 
it suitable for industrial production. However, difficulties arise during the synthesis of 
HA 26, the resultant particles are in the micron range with a wide particle size 
distribution, low surface areas and widespread agglomerate formation. There is an 
inability to effectively control flocculation of particles as they are created in aqueous 
solutions and often an extensive ball-milling step is required to separate the 
agglomerated particles 27. Alternatively, the use of surfactants in precipitation 
reactions has been investigated with moderate success, albeit they do not overcome 
the necessity of time consuming ageing and heat treatment stages 28-31. In this current 
work, Poly(vinyl alcohol) (PVA) was chosen as a surfactant due to its 
biocompatibility and established use in biomedical applications 32,33, whilst, Darvan 
821A® which is a dispersing agent has been reported in literature to disperse 
commercial HA particles in aqueous solutions 34, however, its use during the synthesis 
phase of HA particles has not been previously explored. 
 
The overall goal of this study was to develop and optimise a novel aqueous, low-
temperature rapid precipitation reaction to create non-aggregating particles of nHA 
for incorporation into polymeric scaffolds for tissue engineering applications. The 
aims were to determine the role of reaction pH, the rate of reactant mixing, use of 
sonication, order of addition and concentration of the primary reactants on the 
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formation of nHA. In addition, the effect of using a surfactant (PVA) and dispersing 
agent (Darvan 821A®) on the final product was also examined. In particular, the 
synthesis route presented here is developed with the specific aim of producing a 
calcium phosphate material of the required phase (hydroxyapatite) and suitable 
morphology (monodisperse, non-aggregating particles <100 nm) for incorporation 
into polymeric scaffolds for tissue engineering applications. Potentially, the nHA 
particles could also be utilised as non-viral carriers for gene delivery applications due 
to the mild (low temperature) and rapid aqueous-based reaction conditions in which 
they are synthesized 35,36. 
 
 
2.  Materials and Methods 
2.1 Materials 
The chemicals used in this study were acquired as follows: Analytical reagent grade 
calcium chloride dihydrate (100 %) from Fisher Scientific (Pittsburgh), sodium 
phosphate tribasic dodecahydrate, minimum 98 % and sodium hydroxide anhydrous 
both from Sigma (Dorset). Darvan 821A® was provided by R.T. Vanderbilt 
(Norwalk, CT). Darvan is an ammonium based dispersing agent with polyacrylic acid 
as the active agent. Its molecules are negatively charged along their length and they 
attach to particles causing them to repel each other resulting in a disperse nanophase 
precipitate suspension. Poly(vinyl alcohol) (Sigma, Dorset) was used in solution as a 
surfactant.  A Ca/P ratio of 1.67 was maintained throughout the study by adding 
reactants in the appropriate stoichiometric ratio to ensure the formation of 
hydroxyapatite. 
 
2.2 Preparation of nHA particles 
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We based our initial work on that of Kumta et al. 13, aqueous solutions of CaCl2.2H2O 
(0.41 M) and Na3PO4.12H2O (0.25 M) were prepared using double distilled H2O. 
NaOH was added to the PO4 precursor to control the pH at 10.5. These were mixed 
using drop feeding at a rate of 18,000 ml/hr and adding the Ca precursor to the PO4 
precursor. The precipitation reaction occurred immediately under stirring, according 
to Equation 1. The solution was then centrifuged for 99 mins at 4000 rpm and washed 
to remove the NaCl by-product. The precipitate was resuspended using sonication to 
yield a non-aggregated nHA suspension, or freeze-dried to generate a fine powder. 
These particles will be referred to as our controls herein; all other variants are 
compared to these samples. 
Equation (1) 
10CaCl2.2H2O + 6Na3PO4.12H2O + 2NaOH → Ca10(PO4)6(OH)2 + 20NaCl + 92H2O  
 
2.3 Synthesis parameters 
The following parameters were varied in order to optimise the production of nHA, 
while maintaining a final stoichiometric Ca/P ratio of 1.67. The concentration of the 
initial reactants (Ca concentration: 0.41 M to 0.001 M, PO4 concentration: 0.25 M to 
0.0006 M), the order (Ca into PO4 and vice versa) and the rate of their addition (5, 10, 
300 and 18,000 ml/hr) were altered to establish what effect they had on nHA particle 
formation. In addition, the pH of the reaction was varied from 8 to 12.5 using NaOH 
to establish the effect of pH on the particle size distribution. The use of PVA (1, 3 and 
6 % w/v) and Darvan (0.1 to 1 % v/v) was also investigated by adding the respective 
solutions to the PO4 reactant prior to conducting the precipitation reaction. Each factor 
was varied while keeping all others constant to investigate their role independently. 
The use of sonication was also examined in conjunction with the other factors. 
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2.4 Particle size determination 
Particle size distributions were measured using dynamic light scattering (DLS) 
(ZetaSizer 3000 HS, Malvern instruments, UK).  Measurements were carried out 
under monochromatic, coherent He-Ne laser light of fixed wavelength (633 nm) at 
room temperature with each size determination yielding an average particle size 
expressed as the mean diameter (Zave) together with a graph of the size range.  
 
2.5 Electron microscopy and atomic force microscopy 
Analysis of particle morphology was performed using transmission electron 
microscopy, (JEOL 100CXII TEM, Japan) by placing a drop of nHA suspension onto 
pioloform-coated copper grids and allowing it to dry.  
For scanning electron microscopy (SEM) analysis, aggregated nHA samples were 
adhered to a thin layer of rapid setting epoxy resin on an aluminium specimen stub 
and then sputter coated with gold, using a Polaron Sputter Coater, to a thickness on 10 
nm. Imaging was carried out using a JEOL 840 SEM, operated at 15 kV. In addition, 
nHA suspension was placed onto a silicon disc and dried in a vacuum oven at 60˚C 
for 60 mins in preparation for Atomic Force Microscopy (AFM) imaging. This was 
carried out using a Nanoscope 3A Multimode AFM, operated in tapping mode using 
silicon nitride tips over an area of 25 mm2. 
 
2.6 Physico-chemical characterisation 
The nHA precipitate was freeze dried to yield a fine powder (Advantage EL, Vir-Tis 
Co., Gardiner, NY). The crystal phase of the product was determined using a Bruker 
Advance D8 X-Ray diffractometer (XRD). Cu-Kα radiation (λ = 0.1542 nm) was used 
and all samples were run for 2 hours in the 2θ range from 20–60˚ at a scan speed of 4 
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sec/step using an increment step size of 0.02. Fourier Transform Infra-Red 
spectroscopy (FTIR) analysis was carried out using a Spectrum One FTIR (Perkin 
Elmer, UK). Freeze-dried powders were mixed with potassium bromide using a 
mortar and pestle, before being pressed into a transparent sample. Spectra were 
collected between wavenumbers 4000 and 400 cm-1. 
 
2.7 Statistical analysis  
All data was analysed for significance (p≤0.05) using one-way analysis of variance 
(ANOVA) tests to compare particle size means. Post hoc tests to determine significant 
differences between group means were performed using the Tukey test. 
 
3. Results 
3.1 Particle size analysis 
Hydroxyapatite particles produced in section 2.2, i.e. the non-optimised “control” 
precipitation method using a Ca/P ratio of 1.67, were found to be an average of 24 µm 
in diameter with large deviations. Scanning Electron Microscopy (SEM) revealed that 
aggregates had formed during synthesis as shown in Fig. 1. 
The average particle size decreased significantly after a reduction in the concentration 
of both the calcium and phosphate precursors. The initial calcium solution 
concentration of 0.41 M yielded particles that were immediately visible on 
precipitation. This indicated that they were many microns in size. The calcium 
concentration was sequentially diluted to 0.001 M at which stage the particles were no 
longer visible during the synthesis phase. However, the yield of HA reduced with 
decreasing concentration, and so a lower limit was set at this 0.001 M value (denoted 
concentration X, with concentration 5X having a calcium concentration of 0.005 M, 
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10X having a concentration of 0.01 M). Therefore, reducing the concentration of the 
reactants corresponded to a reduction in aggregate size; however, altering the 
concentration of the precursors alone was not sufficient to prevent aggregation. 
Changing the order of addition of the reactants so that the phosphate solution was 
added to the calcium solution resulted in a significant decrease in particle size (Fig. 
2). However, the rate of reactant addition was not found to have a bearing on the size 
of the resulting precipitate (Fig. 3). The use of sonication was also investigated during 
this study and was found to aid particle size reduction, although it was not sufficient 
to prevent aggregation independently. 
The pH of the reaction was controlled by the addition of sodium hydroxide (NaOH), it 
was established that the particle size was lowest and most consistent at a pH between 
8 and 9.25. As seen in Fig. 4, the particle size rises sharply above pH 9.5.  
A reduction in particle size is evident upon the addition of increasing amounts of PVA 
(Fig. 5a). However, large deviations can be seen due to irregular particle size ranges 
within samples. Preparing the 6 % w/v sample of PVA proved troublesome as it had a 
‘bubbly’ consistency and although it resulted in a 26 fold reduction in aggregate size, 
it also led to a significant decline in the yield. Sonication was not effective when 
working with PVA and actually increased the particle size when compared to non-
sonicated samples. This may be due to the viscous nature of the PVA solution 
dissipating the sonic energy. 
Subsequently, nano-particles of HA were synthesized successfully by using the 
optimal reaction conditions (phosphate solution (0.006 M) added to the calcium 
solution (0.01 M) at a pH of 9.2 with 10 minutes of sonication) with the dispersing 
agent, 0.1% v/v Darvan 821A®. The large random sized agglomerates observed 
previously were replaced by uniformly sized nano-particles in suspension. In 
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comparison between the use of 6 % w/v PVA surfactant vs. 0.1 % v/v Darvan 
dispersant, a smaller average particle size (360 ± 194.7 nm and 140 ± 10.7 nm 
respectively) with a much tighter standard deviation was seen when Darvan 821A® 
was used (Fig. 5b). The required amount of dispersant to prevent aggregation was 
found to be in the range of 0.1 % to 0.5 %. A combination of reduction in particle size 
above 0.1 % and a significant decrease in particle yield above 0.5 % led to this 
determination (Fig. 6). 
Sonication was required to fully disperse the nano particles at higher concentrations. 
Reactions without any dispersant followed by sonication yielded average particle 
sizes in the micron range (23.7 ± 19.3 µm) whereas, the presence of a dispersing agent 
prevented particle agglomeration and reduced the average particle size to 91.9 ± 0.7 
nm following sonication. This is evident in Fig. 7 where the higher concentrations 
yield micron sized aggregates with no sonication, but the sizes could be reduced to 
less than 100 nm after 4 minutes of sonication. In addition, increasing the time of 
sonication up to 12 minutes was shown to reduce particle size further, at which stage 
no further significant reduction was obtained (Fig. 8). 
 
3.2 Microscopical investigation 
Transmission Electron Microscopy (TEM) was used to verify that nHA particles 
generated using the optimised conditions and in the presence of Darvan 821A® 
dispersing agent were non-aggregating rod shaped crystals approximately 30 nm by 
10 nm (Fig. 9a). This is less than the corresponding DLS findings which gave an 
average size of 82.4 ± 11.1 nm. SEM was applied to image aggregated particles 
(section 3.1) while individual nHA particles were viewed using the high resolution of 
Atomic Force Microscopy (AFM). The samples were oven dried before imaging 
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causing some aggregation to occur, which is likely due to static forces arising during 
drying. The heights of individual particles appear to be under 50 nm and particle 
aggregations have approximately similar height dimensions (Fig. 9b). 
 
3.3 Material characterisation 
X-Ray Diffraction (XRD) confirmed the material to be hydroxyapatite without the 
presence of any other calcium phosphate phases (JCPDS 72-1243C). The crystallinity 
of the non-heat treated sample was determined to be 72.9 % and as shown in Fig. 10, 
the crystallinity can be significantly increased on calcination of the sample at 650ºC. 
When nHA made without Darvan is compared to nHA made with Darvan there is a 
close correspondence in their spectra, but with broader peaks observed in the Darvan 
sample (Fig. 11); this may be due to the lack of long range order of the nano crystals. 
There is also a small peak at 22.5˚ 2θ which is attributed to ammonium calcium 
phosphate (JCPDS 21-0697). This is known to decompose to HA over time at room 
temperature 37. Peak broadening occurs and can be used to estimate the crystallite size 
using Scherrer’s equation 38:  
Xs = Kλ/ (βm × Cosθ)                                                                                (2) 
Where Xs is the crystallite size in nm, K is a constant, taken for HA as 0.89, λ the 
wavelength of monochromatic X-Ray beam (0.154 nm); βm the full width at half 
maximum for the diffraction peak under consideration (rad) and θ is the diffraction 
angle (˚). Taking the (002) peak at 25.9˚ 2θ, the crystallite size for nHA made using 
the dispersing agent was determined to be 26.8 nm vs. 50.4 nm for powder made 
using the non-optimised control synthesis. 
Fourier Transform Infra-Red (FTIR) spectra of nHA synthesised both with and 
without the presence of Darvan reveal characteristic peaks for hydroxyapatite; 469, 
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562 and 603 cm-1, with a broad phosphate band evident from 1090 to 980 cm-1 (Fig. 
12). Carbonate peaks are also present in both spectra at 870, 1415 and 1450 cm-1.  
4. Discussion 
The rationale behind developing a quick, low temperature method for synthesizing 
nHA is to enable convenient production of the particles for use in bone tissue 
engineering applications, specifically as a filler material in a composite scaffold or a 
delivery vehicle for plasmid DNA 39. The aqueous suspension is an appropriate form 
for these functions, although the suspension can also be freeze-dried to yield a fine 
nanophase powder if desired. Fine-tuning synthesis methods to construct nano-sized, 
non-aggregating nHA particles has proved difficult, often employing the use of 
surfactants in conjunction with time consuming heating and aging steps in 
precipitation reactions 40,41. Results of this study indicate that controlling reaction 
parameters such as the concentration of initial reactants, pH and the use of sonication 
has important implications for the final product in terms of aggregation and particle 
size. Reducing the calcium and phosphate precursor concentrations correlates to a 
decrease in particle size although a limit is set due to the parallel reduction in product 
yield. This trend agreed with other studies 42 and a range of calcium concentrations, 
from 0.001 M (X) to 0.01 M (10X), was chosen for the rest of this study. The original 
synthesis method (section 2.2) specified the addition of the calcium into the phosphate 
precursor, however, altering this, and combining the use of sonication led to a large 
reduction in aggregation and thus a decrease in resultant particle size. Sonication has 
long been used to disperse solids in a suspension, but to work it must overcome the 
attractive forces between molecules. In this research, it was found that the forces 
between newly forming nHA particles were too strong and sonication alone was not 
sufficient to overpower these.  
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Surprisingly, in this simple chemical precipitation reaction the rate of addition of the 
precursor solutions did not play any significant role on the ensuing particles at optimal 
concentration and order of addition conditions, contrary to previous findings 14. This 
may be due to the optimisation of the protocol for working with these particular 
starting materials and we speculate that the rate of introducing phosphate ions into a 
calcium ion solution is not important if the concentration is sufficient to keep the 
nucleation sites separated, thus preventing widespread aggregation from occurring. 
Without the addition of a surfactant or dispersing agent, the synthesis required strict 
control over reaction pH, maintaining it between 8 and 9.5 in order to minimise 
particle size. It was observed that conducting the reaction above pH 9.5 formed large 
and polydisperse agglomerates, while reactions below pH 7.5 are known to produce 
other forms of calcium phosphate such as brushite (CaHPO4·2H2O) and tri-calcium 
phosphate (Ca3(PO4)2) 13. We recommend that unaided (i.e. no surfactant or 
dispersant) precipitation reactions, synthesizing nHA, should be executed within the 
range pH 8-9.5. 
The factor with the largest effect on aggregation and particle size was established to 
be the use of a dispersing agent. The surfactant, PVA, reduced the particle size range 
from 23.7 ± 19.3 µm to 360 ± 194.7 nm but required a large volume (6 % w/v) to do 
this and a large variability was obtained. In contrast to this, using the dispersing agent, 
Darvan, led to uniformly sized particles of under 100 nm using 0.1 % v/v. This was 
obtained from concentration X (Ca: 0.001 M and PO4: 0.0006 M) up to 10X (Ca: 0.01 
M and PO4: 0.006 M) by utilising sonication. Volumes of the dispersant below 0.1 % 
resulted in no reduction in particle size, while volumes greater than 0.5 % 
significantly reduced the yield.  
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Examining the particles under TEM revealed rod shaped crystals approximately 30 
nm in length, although this is less than 90 nm, which the DLS results indicated. AFM 
showed small crystals beginning to clump together during the oven drying, and these 
individual crystals were approximately under 50 nm in dimension.  
Both FTIR and XRD analysis demonstrated that the dried precipitate is phase pure 
nHA. The broadness of the XRD peaks in the untreated sample is due to the small 
particle size leading to no long range order of crystals (similar to biological HA) 
within the sample, which is contrary to the well defined peaks in the heat-treated 
sample. The spectrum, via the Scherrer’s equation, also reveals the crystallite size of 
the dispersant-aided synthesis to be 26.8 nm, much smaller than the crystallite size 
(50.4 nm) of the particles formed using the initial control method. This value agrees 
closely with the TEM and AFM imaging analysis which shows individual crystals of 
approximately these dimensions. The discrepancy between these results and the DLS 
analysis may be due to the DLS method measuring the hydrodynamic diameter of 
particles, which is larger than the particle size observed using microscopy.  
Therefore, the use of a dispersant in this optimised protocol enables the aqueous-
based production of nHA for use in many applications. Particles of nHA synthesized 
using this method have been incorporated into collagen scaffolds, resulting in a 
composite scaffold with significantly improved mechanical properties and biological 
response compared to a collagen only control 39. Darvan has not been studied 
previously in this regard and we believe it offers much potential in overcoming 
aggregation of HA particles, meriting further examination with alternative synthesis 
methods.  
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5. Conclusions 
Non-aggregating nanoparticles of HA were synthesized using a novel low temperature 
precipitation reaction. Time-consuming heating and ageing treatments to produce the 
nHA crystals were avoided by employing this procedure. The introduction of Darvan 
821A® dispersing agent was the principal factor behind the prevention of 
agglomerate formation. Further significant factors which reduced particle size 
included controlling the reaction pH between 8 and 9.5, decreasing the initial 
concentrations of reactants, using sonication, and changing the original order of 
reactant addition by adding the phosphate precursor to a calcium precursor. The 
resultant nHA particles may potentially be used in a myriad of biomedical 
applications either in a suspension or powder form. 
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Fig 1: Scanning Electron Microscopy (SEM) image showing the aggregation of nanophase 
hydroxyapatite (nHA) particles precipitated without the use of a dispersant (Darvan). 
Fig 2: Graph showing the relationship between average particle size and the order of addition of 
the calcium and phosphate precursors. Additionally, the effect of sonication is shown. (S) = 
sonication used (NS) = no sonication. 
Fig 3:  Graph showing the relationship between average particle size and the rate of addition of 
the calcium and phosphate precursors. 
Fig 4: Graph demonstrating the effect of pH on average particle size; a more variable behaviour 
and larger particles are formed above a reaction pH of 9.5. 
Fig 5: Figure showing the effect of (a) the addition of poly(vinyl alcohol) (PVA) and (b) a 
comparison of using 6 % w/v PVA surfactant vs. 0.1 % v/v Darvan dispersant on the resultant 
average size of nanophase hydroxyapatite (nHA) particles.  
Fig 6: Dynamic Light Scattering (DLS) results displaying the average particle sizes of nanophase 
hydroxyapatite (nHA) prepared with different concentrations (% v/v) of dispersant (Darvan).  
Fig 7: Graph showing the effect of the concentration of the initial reactants (calcium and 
phosphate precursors) on average particle size. Additionally, the effect of sonication (10 mins) is 
also displayed. X: [Ca] = 0.001 M, 5X: [Ca] = 0.005 M, 10X: [Ca] = 0.01 M, Ca/P Ratio = 1.67, S = 
sonication used, NS = no sonication. 
Fig 8: Graph showing average particle size as a function of sonication time. The particles were 
precipitated in the presence of 0.1 % v/v dispersing agent (Darvan) at an initial calcium 
concentration of 0.001 M. 
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Fig 9: (a) Transmission Electron Microscopy (TEM) image showing the morphology of the 
nanophase hydroxyapatite (nHA) particles synthesized using 0.1% v/v Darvan as the dispersing 
agent and, (b) Atomic Force Microscopy (AFM) image showing how the particles tend to re-
aggregate slightly due to static forces following oven drying. 
Fig 10: X-Ray Diffraction (XRD) spectra of the as-prepared nHA synthesized with Darvan 
(bottom spectrum), and the same sample after calcination at 650ºC (top spectrum). 
Fig 11: The broader XRD spectrum (b) shows the presence of a small peak at 22.5˚ 2θ indicating 
the presence of ammonium calcium phosphate compared to the HA spectrum synthesized using 
the original “control” synthesis (a). 
Fig 12: Fourier Transform Infra-Red (FTIR) spectra of nHA particles synthesized in the absence 
(a) and presence (b) of the dispersant, Darvan.  
